Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe 0.25mg dose is where every Wegovy journey begins — and in the UK private market, the cost of that starting pen sits within a range that varies more by provider than by dose. Private Wegovy pricing is set per monthly supply and is not meaningfully lower at 0.25mg than at higher strengths with most services, because you're paying for the clinical infrastructure around it as much as the medicine itself. Wegovy is a prescription-only medicine, which means any legitimate route to it requires a clinical assessment first — a prescriber decides whether it's right for you, not a checkout basket.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE's recommendation for semaglutide (Wegovy) under TA875 describes a treatment that begins at a low dose and escalates over time, with clinical review at each stage. The 0.25mg weekly injection is established as the starting point in the licensed schedule, a dose designed to let your system adjust rather than to drive weight loss from day one. That's not a flaw or a shortcut; it's how the medicine is designed to be used safely.
Because of this, many people asking about Wegovy 0.25mg cost are really asking about the cost of getting started. That's a fair question. If you want to go straight to the numbers, our page covering the Wegovy 0.25mg price sets out what you can expect to pay in the UK private market. You'll find a fuller breakdown of Wegovy costs across the schedule if you want to understand what subsequent months look like.
One misconception worth gently addressing: some people expect the starter dose to be substantially cheaper because it contains less active medicine per injection. In practice, the cost of a private prescription reflects the service around it (the prescriber's time, the pharmacy's overheads, regulated dispensing) not just the quantity of semaglutide in the pen.
When you see a figure advertised for Wegovy online, it's worth pausing to ask what that number includes. A number of providers charge separately for the consultation, the prescription, and delivery, meaning the starting figure and the real monthly outgoing can differ considerably. Understanding the full Wegovy price, not just the headline, is the more useful comparison.
Following Eli Lilly's list-price increase for tirzepatide in September 2025, private GLP-1 pricing across the market has shifted. Wegovy pricing in the UK private sector has been reported to range roughly £149 to £375 per month depending on provider, strength and what is or isn't bundled in. Those figures should be treated as indicative, they can shift, and what one provider includes for that amount varies significantly. The NHS medicines page for semaglutide sets out what the medicine is and how it works, though private pricing is set by individual services.
What genuinely matters is whether the fee you pay covers clinical review before every repeat, access to support if something feels wrong mid-treatment, and evidence that the pharmacy dispensing it is registered and regulated. That's the structure that makes treatment both safe and sustainable.
Our starting point is transparency. One price at nume covers the consultation, the prescription review, the medicine, and free next-working-day delivery. There's no subscription and no auto-renewal, every repeat order is reviewed clinically before it goes out. If a prescriber isn't satisfied with the evidence or your health picture has changed, the repeat doesn't go ahead. That's how it should work.
We're not the cheapest option on the market. That's a deliberate choice. The race to the lowest price for prescription medicines tends to cut corners on the things that matter: clinical review time, aftercare access, supply-chain integrity. Our clinical team reviews every consultation personally, and our GPhC-registered pharmacy (registration number 9012878, verifiable on the GPhC register) operates within MHRA-regulated supply chains.
If you'd like to explore how results tend to develop from the starting dose, our page on weight loss at 0.25mg Wegovy covers what the clinical evidence actually says at that stage.
Price comparison makes sense for many things. For a prescription-only medicine that affects your metabolism, appetite, and gastrointestinal system, the cheapest listing often answers the wrong question entirely. The MHRA has warned publicly about counterfeit semaglutide pens sold online, some containing entirely different substances. Sellers offering Wegovy without a clinical assessment, through social media or via codes from unverified sources, are a red flag, not a bargain. You can report suspect sellers through the MHRA's Yellow Card scheme.
The right measure for any Wegovy service is whether a qualified prescriber is making the decision, whether the pharmacy is GPhC-registered and can be verified independently, and whether there's clinical support available if something doesn't feel right. Those are the questions that keep treatment safe. If you're weighing up what to expect at this stage, our pages on how much weight you can lose on 0.25mg Wegovy and what weight loss to expect personally on 0.25mg Wegovy explain what the evidence shows. Learn more about how Wegovy works, or if you're ready to take the next step, the consultation is free and there's no obligation after it.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.